← Eichor
Study identifier: NCT06583148 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Smoke-Free Home Intervention in Tribal Communities

Condition: Tobacco-Related Carcinoma  ·  Sponsor: Emory University

PhaseNA
Planned participants575
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.

This description comes directly from the study's public registry record.

Talk to the study team

Josh Kaufmann  ·  404-727-7718  ·  josh.kaufmann@emory.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Emory University Hospital/Winship Cancer InstituteAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06583148